Litigator of the Week Honors for Patent Trial Success
August 12, 2022
Matthew Murphy was honored in The American Lawyer’s “Litigator of the Week” column for Axinn’s trial success on behalf of Alvogen affiliate Norwich Pharmaceuticals in its defense of patent claims asserted by Bausch Health subsidiary Salix Pharmaceuticals. The column noted that the “key ruling” for Norwich, which is seeking to market a generic version of Salix’s blockbuster product Xifaxan®, led to a halt in trading of Bausch Health stock, which dropped more than 50% after news of the judge’s decision. The “Litigator of the Week” feature focuses on cases with “high stakes, long odds,” and “an impact, where the outcome matters to more than just the parties involved.”
Other key members of Axinn’s trial team include Matt Becker, Aziz Burgy, Rebecca Clegg, Ricky Camposanto, and Chantelle Ankerman.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
Volunteer Lawyers for the Arts – Champions of the Arts Awards and Gala 2025
Sponsorship
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Cost-Effective and Efficient IP Litigation Strategies – Making Paragraph IV Litigation Work for You
Webinar
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
Recent Decision Shows the Heavy Burden of Actual Malice in Defamation Suits
Axinn Viewpoints
Litigation & Trials